Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
If you think about a patient who has diabetes, hypertension, fatty liver disease or kidney disease, that patient may seek care from three or four specialists who usually work in silos in their own areas, says Sergiu Darabant, M.D., a medical cardiologist Miami Cardiac & Vascular Institute
While this class of medications is generally considered safe and effective, potentially severe neurological complications may be associated with rapid weight loss and nutritional deficiencies following GLP-1 agonist use
This latest approval for Wegovy simply allows doctors to formally expand treatment to a larger group of people: those with overweight or obesity who have cardiovascular disease but not diabetes
These data underline the importance of optimal glycemic control and call for major pharmacological interventions to reduce the risk of cardiometabolic-related cognitive impairment
